Data, Clinical Trials, Clinical Research, Privacy, Safety.
reach. However, these technologies also raise new privacy concerns. Anonymized data, if not handled correctly, can often be re-identified, posing a significant risk to participant confidentiality. Consent and transparency are pivotal in navigating the data dilemma. Informed consent processes must